Michigan State: Faculty Voice - Alzheimer's, the FDA, and Aducanumab
July 31, 2021
July 31, 2021
EAST LANSING, Michigan, July 31 (TNSOps) -- Michigan State University issued the following commentary:
* * *
By Leonard Fleck
Professor, The Center for Bioethics and Social Justice in the College of Human Medicine
At this writing three members of the FDA Advisory Committee have chosen to resign in protest over the FDA's decision to approve aducanumab for the treatment of mild cognitive impairment. This decision is commendable. However, it . . .
* * *
By Leonard Fleck
Professor, The Center for Bioethics and Social Justice in the College of Human Medicine
At this writing three members of the FDA Advisory Committee have chosen to resign in protest over the FDA's decision to approve aducanumab for the treatment of mild cognitive impairment. This decision is commendable. However, it . . .